Form 4: Avista Capital Partners and Joshua Tamaroff Report Changes in Beneficial Ownership of OmniAb, Inc. Shares Following Director's Resignation

Avista Capital Partners and former director Joshua Tamaroff report transactions involving OmniAb, Inc. shares, including option exercises and forfeitures, following Tamaroff's resignation.

Summary

• Avista Capital Partners and related entities, along with former director Joshua Tamaroff, filed a Form 4 detailing changes in their beneficial ownership of OmniAb, Inc. (OABI) securities.
• The filing reports transactions occurring on June 28 and June 29, 2024.
• Joshua Tamaroff resigned as a director of OmniAb, Inc. effective June 28, 2024, leading to the forfeiture of unvested restricted stock units (RSUs) and stock options.
• Avista Capital Partners V, L.P. directly holds 7,296,895 shares of common stock and 5,224,114 warrants.
• Avista Capital Partners (Offshore) V, L.P. directly holds 8,565,920 shares of common stock and 6,121,375 warrants.
• Stock options were exercised on a net share settlement basis, resulting in the issuance of 7,111 shares of common stock.
• 59,557 shares were withheld by the issuer to cover the exercise price and withholding taxes related to the option exercise.
• 1,293,299 shares of common stock are subject to potential forfeiture if a 'Triggering Event' does not occur during the 'Earnout Period' as defined in a letter agreement.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The resignation of a director is a slightly negative event, but the stock option exercise is a slightly positive one. Overall, the sentiment is neutral.

Positives

• The exercise of stock options indicates a belief in the company's future prospects, albeit on a net share settlement basis.

Negatives

• The resignation of a director, Joshua Tamaroff, could be perceived negatively, although the document doesn't provide reasons for the resignation.
• Forfeiture of unvested RSUs and stock options due to the director's resignation represents a loss of potential equity for the individual.

Risks

• The potential forfeiture of 1,293,299 shares of common stock if the 'Triggering Event' does not occur could impact the share price.
• The document mentions transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, which could limit the liquidity of certain shares.

Future Outlook

The document does not contain explicit forward-looking statements, but it does reference ongoing agreements and potential future events like the 'Triggering Event' and the 'Earnout Period' that could impact share ownership.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading and provide investors with information about the ownership positions of company insiders. The resignation of a director and subsequent changes in ownership are events that investors typically monitor closely.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency of insider transactions.
• Companies like Amgen, Regeneron, and AbbVie also have similar filings when their executives or major shareholders trade company stock.
• The reporting requirements and timelines are consistent across the industry, as mandated by the SEC.

Management Changes

Stakeholder Impact

• Shareholders may be interested in the changes in ownership and the potential forfeiture of shares.
• Employees may be indirectly affected by changes in the board of directors.
• The resignation of a director could potentially impact the company's strategic direction.

Next Steps

• Monitoring the occurrence of the 'Triggering Event' within the 'Earnout Period' to determine if the 1,293,299 shares will be forfeited.
• Observing any further changes in beneficial ownership by Avista Capital Partners and related entities.

Key Dates